Title: New Medical Therapies in Inflammatory Bowel Diseases In 2017
Abstract: A significant progress has been made regarding the management of inflammatory bowel disease (IBD) over the past 38 years as shown in Table 1. Our therapeutic goals in IBD are summarized in Table 2. Only limited treatment options existed until the introduction of anti-tumor necrosis factor (anti-TNF) agents, which was a landmark in the management of these debilitating diseases.